These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 423177)

  • 1. Molecular orbital study on the reaction mechanism of irreversible enzyme inhibitors.
    Nagata C; Yamaguchi T
    J Med Chem; 1979 Jan; 22(1):13-7. PubMed ID: 423177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A side reaction of alanine racemase: transamination of cycloserine.
    Fenn TD; Stamper GF; Morollo AA; Ringe D
    Biochemistry; 2003 May; 42(19):5775-83. PubMed ID: 12741835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the irreversible inhibition of aspartate aminotransferase by the bacterial toxin L-2-amino-4-methoxy-trans-3-butenoic acid.
    Rando RR; Relyea N; Cheng L
    J Biol Chem; 1976 Jun; 251(11):3306-12. PubMed ID: 6451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of alanine racemase enzyme: a review.
    Azam MA; Jayaram U
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):517-26. PubMed ID: 26024289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of alanine aminotransferase and aspartate aminotransferase in rat hepatocytes.
    Cornell NW; Zuurendonk PF; Kerich MJ; Straight CB
    Biochem J; 1984 Jun; 220(3):707-16. PubMed ID: 6466297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible inhibition of aspartate aminotransferase by 2-amino-3-butenoic acid.
    Rando RR
    Biochemistry; 1974 Sep; 13(19):3859-63. PubMed ID: 4472160
    [No Abstract]   [Full Text] [Related]  

  • 7. Active-site labeling of aspartate aminotransferases by the beta,gamma-unsaturated amino acid vinylglycine.
    Gehring H; Rando RR; Christen P
    Biochemistry; 1977 Nov; 16(22):4832-6. PubMed ID: 911793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Y265F mutant on the transamination-based cycloserine inactivation of alanine racemase.
    Fenn TD; Holyoak T; Stamper GF; Ringe D
    Biochemistry; 2005 Apr; 44(14):5317-27. PubMed ID: 15807525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral discrimination among aminotransferases: inactivation by 4-amino-4,5-dihydrothiophenecarboxylic acid.
    Lepore BW; Liu D; Peng Y; Fu M; Yasuda C; Manning JM; Silverman RB; Ringe D
    Biochemistry; 2010 Apr; 49(14):3138-47. PubMed ID: 20192272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of specific aminotransferases in de novo glutamate synthesis and redox shuttling in the retina.
    LaNoue KF; Berkich DA; Conway M; Barber AJ; Hu LY; Taylor C; Hutson S
    J Neurosci Res; 2001 Dec; 66(5):914-22. PubMed ID: 11746419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transamination as a side-reaction catalyzed by alanine racemase of Bacillus stearothermophilus.
    Kurokawa Y; Watanabe A; Yoshimura T; Esaki N; Soda K
    J Biochem; 1998 Dec; 124(6):1163-9. PubMed ID: 9832621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-steady-state kinetics of Escherichia coli aspartate aminotransferase catalyzed reactions and thermodynamic aspects of its substrate specificity.
    Kuramitsu S; Hiromi K; Hayashi H; Morino Y; Kagamiyama H
    Biochemistry; 1990 Jun; 29(23):5469-76. PubMed ID: 2201406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1-Amino-2-propenyl) phosphonic acid, an inhibitor of alanine racemase and D-alanine:D-alanine ligase.
    Vo-Quang Y; Carniato D; Vo-Quang L; Lacoste AM; Neuzil E; Le Goffic F
    J Med Chem; 1986 Apr; 29(4):579-81. PubMed ID: 2870190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Molecular Modeling Studies of Some Mycobacterium Tuberculosis Alanine Racemase Inhibitors.
    Jayaram U; Azam MA
    Acta Chim Slov; 2022 Jun; 69(2):393-404. PubMed ID: 35861096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit interaction of monomeric alanine racemases from four Shigella species in catalytic reaction.
    Yokoigawa K; Okubo Y; Soda K
    FEMS Microbiol Lett; 2003 Apr; 221(2):263-7. PubMed ID: 12725937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and mechanism of a cysteine sulfinate desulfinase engineered on the aspartate aminotransferase scaffold.
    Fernandez FJ; de Vries D; Peña-Soler E; Coll M; Christen P; Gehring H; Vega MC
    Biochim Biophys Acta; 2012 Feb; 1824(2):339-49. PubMed ID: 22138634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of substrate structural analogues on the enzymatic activities of aspartate aminotransferase isoenzymes.
    Martins LL; Mourato MP; de Varennes A
    J Enzyme Inhib; 2001; 16(3):251-7. PubMed ID: 11697045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical arginine residue in cytosolic aspartate aminotransferase from pig heart.
    Miyawaki M; Tanase S; Morino Y
    J Biochem; 1982 Mar; 91(3):989-99. PubMed ID: 7076657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Asp222 in the catalytic mechanism of Escherichia coli aspartate aminotransferase: the amino acid residue which enhances the function of the enzyme-bound coenzyme pyridoxal 5'-phosphate.
    Yano T; Kuramitsu S; Tanase S; Morino Y; Kagamiyama H
    Biochemistry; 1992 Jun; 31(25):5878-87. PubMed ID: 1610831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labilization of the phosphoester linkage in enzyme-inhibitor complexes of aspartate aminotransferase.
    Khurs EN; Severin ES; Dixon HB; Khomutov RM
    Mol Biol (Mosk); 1976; 10(4):740-7. PubMed ID: 15213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.